“Efficacy of Topical Difluprednate in Control of Inflammation after Phacoemulsification”, J. Natl. Inst. Ophthalmol, vol. 5, no. 2, pp. 37–41, Jun. 2022, doi: 10.3329/jnio.v5i2.66790.